Table 3.
Variable | Model 1 All survivors |
Model 2 Survivors with and without new cancers |
||
---|---|---|---|---|
| ||||
Females (N=3701) | ||||
| ||||
OR | 95% CI | OR | 95% CI | |
Cancer survivorship | ||||
All survivors (N=383) | 2.14** | 1.62–2.83 | ||
Survivors with any new cancers (N=68) | 3.05** | 1.76–5.30 | ||
Cancer-free survivors (N=311) | 1.94** | 1.43–2.63 | ||
Chronic conditions | ||||
Diabetes (N=556) | 1.54** | 1.23–1.92 | 1.54** | 1.23–1.92 |
Chronic lung disease (N=345) | 2.63** | 2.03–3.42 | 2.63** | 2.03–3.42 |
Heart disease (N=550) | 2.91** | 2.34–3.61 | 2.91** | 2.34–3.62 |
Stroke (N=167) | 2.26** | 1.56–3.28 | 2.25** | 1.55–3.26 |
Arthritis/rheumatism (N=2193) | 3.37** | 2.78–4.09 | 3.36** | 2.77–4.07 |
No cancer/No chronic conditions (N=1021) | 1.00 | 1.00 | ||
| ||||
Males (N=2810) | ||||
| ||||
Cancer survivorship | ||||
All survivors (N=251) | 2.34** | 1.63–3.36 | ||
Survivors with any new cancers (N=48) | 5.14** | 2.59–10.20 | ||
Cancer-free survivors (N=201) | 1.89** | 1.25–2.84 | ||
Chronic conditions | ||||
Diabetes (N=501) | 2.02** | 1.57–2.60 | 2.04** | 1.58–2.62 |
Chronic lung disease (N=210) | 4.89** | 3.46–6.90 | 4.88** | 3.45–6.89 |
Heart disease (N=554) | 2.34** | 1.84–2.98 | 2.32** | 1.83–2.96 |
Stroke (N= 143) | 3.86** | 2.55–5.85 | 3.78** | 2.50–5.72 |
Arthritis/rheumatism (N=1261) | 2.88** | 2.31–3.60 | 2.92 | 2.34–3.65 |
No cancer/No chronic conditions (N=969) | 1.00 | 1.00 |
OR: odds ratio. 95% CI: 95% confidence interval.
Statistically significant in a two-tailed test (p<0.01).
The reference group is adults who are not cancer survivors and have no chronic conditions. The odds ratio for the reference group is 1. Odds ratios are adjusted for age, race, education, marital status at diagnosis/baseline, employment status at diagnosis/baseline, occupation at diagnosis/baseline, and health insurance from own employer at diagnosis/baseline.